Eledon Pharmaceuticals News

Analysts Are Bullish on These Healthcare Stocks: Eledon Pharmaceuticals (ELDN), Opthea Limited Sponsored ADR (OPT)

TipRanksSep 9 02:22 ET

Buy Rating Justified by Eledon Pharmaceuticals' Strategic Progress and Growth Potential

TipRanksAug 22 00:57 ET

Leerink Partners Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsAug 16 03:31 ET

LifeSci Capital Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsAug 15 08:31 ET

Eledon Pharmaceuticals (ELDN) Receives a Buy From Noble Financial

TipRanksJul 30 08:36 ET

Noble Financial Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsJul 30 08:31 ET

Eledon Pharma Analyst Ratings

BenzingaJun 4 06:17 ET

Eledon Pharma Analyst Ratings

BenzingaMay 10 15:27 ET

Eledon Pharmaceuticals' Tegoprubart Shows Promising Trial Results and Fuels Buy Rating

TipRanksMay 10 01:30 ET

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Agenus (AGEN)

TipRanksMay 8 08:41 ET

Eledon Pharmaceuticals' Tegoprubart Shows Promising Clinical Advancements, Reinforcing Buy Rating and Elevated Price Target

TipRanksMay 7 10:31 ET

Eledon Pharma Analyst Ratings

BenzingaMay 7 10:17 ET

Eledon Pharmaceuticals Risks Shareholder Equity Dilution Amidst Private Placement and Potential Stock Issuances

TipRanksMar 30 02:05 ET

Eledon Pharma Analyst Ratings

BenzingaMar 22 06:32 ET

Eledon Pharmaceuticals: A Buy Rating on Breakthrough Organ Transplant Solutions

TipRanksMar 21 18:20 ET

Analysts Offer Insights on Healthcare Companies: Recursion Pharmaceuticals (RXRX), Edgewise Therapeutics (EWTX) and Eledon Pharmaceuticals (ELDN)

TipRanksNov 14, 2023 02:30 ET

HC Wainwright & Co. Reiterates Buy on Eledon Pharma, Maintains $13 Price Target

BenzingaNov 13, 2023 07:47 ET

Eledon Pharma Analyst Ratings

BenzingaNov 13, 2023 07:45 ET

Eledon Pharmaceuticals Receives Buy Rating: Successful Tegoprubart Trials & Strong Financial Status Contribute to Positive Outlook

TipRanksNov 10, 2023 10:15 ET

Promising Phase Ib Study Results Bolster Buy Rating for Eledon Pharmaceuticals: An Analysis by Rami Katkhuda

TipRanksNov 3, 2023 08:45 ET